19092-Solid Tumors-NA-458

Solid Tumors

A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)

  • Details

ClinicalTrials.gov ID: NCT04083976
Diagnosis Type: NA
USOR Number: 19092

  • Address

4708 Alliance Blvd, Suite 150
Plano, TX 75093
P: (972) 596-7801

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.